Dialysis & Nephrology Digest - October 2020 #2


Possible settlement in class action involving ARA and stockholders -

The U.S. District Court for the District of New Jersey will consider a proposed settlement of class action case involving individuals who purchased common stock in American Renal Associates between Aug. 10, 2016 and Mar. 27, 2019. It’s alleged the defendants made false statements concerning ARA’s financial results, including that they were prepared in compliance with GAAP and the adequacy of their internal controls. If approved, the settlement would result in a payout of $5,775,000, plus interest and minus attorney fees and other expenses, to the class. The hearing to discuss the proposed settlement is set for Jan. 12.

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Benesch | Attorney Advertising

Written by:


Benesch on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.